Venturi Wealth Management LLC Acquires 1,682 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Venturi Wealth Management LLC increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 35.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,381 shares of the medical device company’s stock after purchasing an additional 1,682 shares during the quarter. Venturi Wealth Management LLC’s holdings in Cooper Companies were worth $587,000 as of its most recent filing with the SEC.

A number of other large investors have also bought and sold shares of COO. Victory Capital Management Inc. grew its stake in shares of Cooper Companies by 23.0% during the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after acquiring an additional 737,726 shares in the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of Cooper Companies during the 4th quarter worth approximately $691,000. Highland Capital Management LLC bought a new position in shares of Cooper Companies during the 4th quarter worth approximately $4,004,000. Franklin Resources Inc. grew its stake in shares of Cooper Companies by 194.0% during the 3rd quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock worth $5,265,000 after acquiring an additional 32,260 shares in the last quarter. Finally, Principal Financial Group Inc. grew its stake in shares of Cooper Companies by 6.6% during the 3rd quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock worth $26,295,000 after acquiring an additional 14,687 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Trading Down 1.0 %

Shares of Cooper Companies stock opened at $86.46 on Thursday. The business has a fifty day simple moving average of $93.23 and a two-hundred day simple moving average of $99.65. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The company has a market capitalization of $17.26 billion, a price-to-earnings ratio of 44.34, a P/E/G ratio of 2.23 and a beta of 1.00. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter last year, the firm posted $0.87 EPS. The company’s quarterly revenue was up 9.8% on a year-over-year basis. Research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Wells Fargo & Company raised their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Morgan Stanley decreased their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Finally, Citigroup decreased their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.